MYQORZOPriority claimed from 04/10/2022; Application No. : 97619234 ;United States of America (Class 5)
#5866470
Application Number:5866470
Status:
Unknown
Class:5
Applicant: Cytokinetics, Incorporated
Filing Date:Mon, 27 Mar 2023
Get a free email alert the moment this application's status changes.
Trademark Information
| Trademark | MYQORZOPriority claimed from 04/10/2022; Application No. : 97619234 ;United States of America |
| Trademark Type | Wordmark |
| Class | 5 |
| Application Number | 5866470 |
| Nature/Scope of business | Pharmaceutical preparations for human use, namely, medications to treat cardiovascular conditions; pharmaceutical preparations to treat hypertrophic cardiomyopathies, heart failure, and heart failure with preserved ejection fraction. |
| Publication | In Journal No. 2127 |
| Status | Unknown |
| Applicant: | Cytokinetics, Incorporated |
| Applicant Address | 350 Oyster Point Boulevard, South San Francisco, California 94080, U.S.A. a corporation of Delaware |
| Jurisdiction | DELHI |
| Agent | FIDUS LAW CHAMBERS |
| Agent Address | Flat No. 021, Mahagun Maestro Plot No. F21A Sector 50 Noida - 201301 |
Frequently Asked Questions
Who is the owner of trademark MYQORZOPriority claimed from 04/10/2022; Application No. : 97619234 ;United States of America? ▾
The trademark application number 5866470 is owned by Cytokinetics, Incorporated.
Which class does trademark MYQORZOPriority claimed from 04/10/2022; Application No. : 97619234 ;United States of America belong to? ▾
Trademark application number 5866470 is filed under Class 5, which relates to the specified goods and services.
Who is the trademark agent for application 5866470? ▾
The trademark agent associated with application number 5866470 is FIDUS LAW CHAMBERS.
Was trademark MYQORZOPriority claimed from 04/10/2022; Application No. : 97619234 ;United States of America published in the journal? ▾
Yes, trademark application number 5866470 was published in Journal No. 2127.
What is trademark MYQORZOPriority claimed from 04/10/2022; Application No. : 97619234 ;United States of America? ▾
Trademark application number 5866470 relates to "Pharmaceutical preparations for human use, namely, medications to treat cardiovascular conditions; pharmaceutical preparations to treat hypertrophic cardiomyopathies, heart failure, and heart failure with preserved ejection fraction.".
File Trademark at Just ₹1,499 + Govt Fees
Get your trademark registered with expert guidance. Limited time offer!
File NowExpert Consultation
Quick Processing
100% Support
Free Report
Get Detailed Trademark Report
Comprehensive analysis of your trademark search delivered to your phone
What you'll get:
- Complete trademark analysis
- Conflict assessment
- Registration guidance
15,000+Trademarks Filed
98%Success Rate
Govt Authorized
ISO Certified